Denali Therapeutics, Inc. (DNLI)
18.95
-0.50
(-2.57%)
USD |
NASDAQ |
Oct 12, 16:00
19.05
+0.10
(+0.53%)
After-Hours: 05:42
Denali Therapeutics Net Income (TTM) : -511.45M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -511.45M |
| March 31, 2026 | -508.02M |
| December 31, 2025 | -512.54M |
| September 30, 2025 | -498.74M |
| June 30, 2025 | -479.03M |
| March 31, 2025 | -453.94M |
| December 31, 2024 | -422.77M |
| September 30, 2024 | -427.49M |
| June 30, 2024 | -419.65M |
| March 31, 2024 | -137.24M |
| December 31, 2023 | -145.22M |
| September 30, 2023 | -124.43M |
| June 30, 2023 | -128.38M |
| March 31, 2023 | -370.55M |
| December 31, 2022 | -325.99M |
| September 30, 2022 | -302.57M |
| June 30, 2022 | -283.86M |
| March 31, 2022 | -285.76M |
| December 31, 2021 | -290.58M |
| Date | Value |
|---|---|
| September 30, 2021 | 29.56M |
| June 30, 2021 | 55.92M |
| March 31, 2021 | 57.86M |
| December 31, 2020 | 71.14M |
| September 30, 2020 | -227.77M |
| June 30, 2020 | -215.81M |
| March 31, 2020 | -215.38M |
| December 31, 2019 | -197.61M |
| September 30, 2019 | -66.06M |
| June 30, 2019 | -55.17M |
| March 31, 2019 | -51.55M |
| December 31, 2018 | -36.24M |
| September 30, 2018 | -136.66M |
| June 30, 2018 | -123.13M |
| March 31, 2018 | -90.54M |
| December 31, 2017 | -88.18M |
| September 30, 2017 | -84.65M |
| June 30, 2017 | -93.42M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |
| Sarepta Therapeutics, Inc. | -266.10M |
| Anixa Biosciences, Inc. | -10.47M |